NDC 0781-7216-06 - BUPRENORPHINE AND NALOXONE
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 0781-7216
- Requested NDC
- 0781-7216-06
- Package NDCs from labels
- 0781-7216-06, 0781-7216-64
- Manufacturer
- Indivior Inc.
- Effective date
- 2021-04-19
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| BUPRENORPHINE AND NALOXONE - Indivior Inc. | Indivior Inc. | 2021-04-19 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 0781-7216-06 | EA - Each | 0781-7216 | c660ea43-9460-4969-b54c-1c715912e4ab | 1 | 2019-07-02 |
| 0781-7216-64 | EA - Each | 0781-7216 | 6ce94f64-6daa-4aa0-9ea0-de7a32ea6cb6 | 1 | 2019-03-12 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Artificial Tears | GLYCERIN | Geri-Care Pharmaceuticals, Corp | 7cc437e3-bad9-59be-e053-2991aa0a1da3 | 2025-12-19 | Warnings | 3NXW29V3WO |
| Sterile Cord Blood Collection Unit (MSC128D) | ANTICOAGULANT CITRATE PHOSPHATE DEXTROSE SOLUTION | Maco Productions | 251fd4cb-4aa4-4473-9f89-968da856eb77 | 2025-12-18 | Warnings | 2968PHW8QP 1Q73Q2JULR |
| Sterile Cord Blood Collection Unit (MSC127D) | ANTICOAGULANT CITRATE PHOSPHATE DEXTROSE SOLUTION | Maco Productions | 75a008b2-9666-4bfa-ab18-6d09b43b2215 | 2025-12-18 | Warnings | 2968PHW8QP 1Q73Q2JULR |
| Buprenorphine Hydrochloride | BUPRENORPHINE HYDROCHLORIDE | Par Health USA, LLC | 34767dda-ce52-4f98-a45f-bb5cee0cd5e6 | 2025-12-18 | Boxed warning, Warnings, Adverse reactions | 56W8MW3EN1 |
| Pall Sterile Cord Blood Collection Unit | STERILE CORD BLOOD COLLECTION UNIT | Global Life Sciences Solutions USA LLC | aa9340b7-cc63-e17d-e053-2a95a90ad4d9 | 2025-12-18 | Warnings | 2968PHW8QP 1Q73Q2JULR |
| STERILE CORD BLOOD COLLECTION UNIT (MSC123D) | ANTICOAGULANT CITRATE PHOSPHATE DEXTROSE | Maco Productions | e3b456ec-4578-485f-a696-8a343505f30b | 2025-12-16 | Warnings | 2968PHW8QP 1Q73Q2JULR |
| Artificial Tears | GLYCERIN | NuCare Pharmaceuticals,Inc. | 97a3d8e2-b2c0-3f5d-e053-2a95a90ac49d | 2025-12-15 | Warnings | 3NXW29V3WO |
| Buprenorphine and Naloxone | BUPRENORPHINE AND NALOXONE | Redpharm Drug | 374530e2-3b2e-77d7-e063-6394a90a37c9 | 2025-12-11 | Warnings, Adverse reactions | 56W8MW3EN1 |
| PaxLyte | LEUCOVORIN, FOLIC ACID, LEVOMEFOLATE MAGNESIUM, FERROUS CYSTEINE GLYCINATE, 1,2-DOCOSAHEXANOYL-SN-GLYCERO-3-PHOSPHOSERINE CALCIUM, 1,2-ICOSAPENTOYL-SN-GLYCERO-3-PHOSPHOSERINE CALCIUM, PHOSPHATIDYL SERINE, PYRIDOXAL 5-PHOSPHATE, FLAVIN ADENINE DINUCLEOTIDE, NADH, COBAMAMIDE, COCARBOXYLASE (THIAMINE PYROPHOSPHATE), MAGNESIUM ASCORBATE, ZINC ASCORBATE, MAGNESIUM L-THREONATE AND BETAINE CAPSULE | Jaymac Pharmaceuticals | f520b130-61b3-443e-aaf6-91e094e7a334 | 2025-12-08 | Warnings, Adverse reactions | 2968PHW8QP 1Q73Q2JULR |
| Narcan | NALOXONE HYDROCHLORIDE | Emergent Devices Inc. | 724df050-5332-4d0a-9a5f-17bf08a547e1 | 2025-12-05 | Warnings, Adverse reactions | F850569PQR |
| ZIMHI | NALOXONE HYDROCHLORIDE | ZMI Pharma Inc. | 523c0909-bff6-4010-988a-53de18b7cb3f | 2025-12-04 | Warnings, Adverse reactions | F850569PQR |
| Alka-Seltzer Heartburn | ANHYDROUS CITRIC ACID, SODIUM BICARBONATE (HEAT-TREATED) | Bayer HealthCare LLC. | 55158e50-0327-2043-e054-00144ff8d46c | 2025-12-04 | Warnings | 2968PHW8QP |
| Alka-Seltzer Gold | ALKA-SELTZER GOLD | Bayer HealthCare LLC. | 0824bedb-413b-2fa0-e054-00144ff88e88 | 2025-12-04 | Warnings | 2968PHW8QP |
| Buprenorphine | BUPRENORPHINE | Redpharm Drug | 3dd00186-1f1f-642a-e063-6294a90a6d20 | 2025-12-02 | Warnings, Adverse reactions | 56W8MW3EN1 |
| ACD-A | ANTICOAGULANT CITRATE DEXTROSE SOLUTION FORMULA A | Fenwal, Inc. | ab19b011-0a51-4f04-9881-d9fc7cae95ae | 2025-11-25 | 1Q73Q2JULR | |
| NALOXONE HYDROCHLORIDE | NALOXONE HYDROCHLORIDE | Strategic Sourcing Services LLC | 577fbd57-7054-4536-86c1-d43bc99cc7b1 | 2025-11-19 | Warnings | F850569PQR |
| Earthmed Soothe Chewable Orange | CITRIC ACID | Earthmed LLC | 439543fe-ceb9-4c5c-e063-6294a90a9b70 | 2025-11-14 | Warnings | 2968PHW8QP |
| Naloxone Hydrochloride | NALOXONE HYDROCHLORIDE | ProPharma Distribution | 3f2bb95a-aeca-c0b7-e063-6394a90a627b | 2025-09-19 | Warnings, Adverse reactions | F850569PQR |
| Naloxone Hydrochloride | NALOXONE HYDROCHLORIDE | Hikma Pharmaceuticals USA Inc. | e6467385-6990-498c-8a0e-f4a40ef33cb7 | 2025-09-02 | Warnings, Adverse reactions | F850569PQR |
| NALOXONE HYDROCHLORIDE | NALOXONE HYDROCHLORIDE | AMERISOURCE BERGEN | cce38c13-0d2f-49bb-94fa-6f2bbb4d5984 | 2025-08-31 | Warnings | F850569PQR |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.